Clinical trial
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With…
NCT00141206 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141206 |
|---|---|
| Title | A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation |
| Official title | A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | varenicline (CP-526, 555) |
| Enrollment | 1,005 |
| Start date | May 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Jun 4, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: